Meyka Pro banner
Stevanato Group S.p.A.

Stevanato Group S.p.A. (STVN) Stock Overview

Explore Stevanato Group S.p.A.’s financial performance, market position, analyst ratings, and future outlook.

STVNNYSE
HealthcareMedical - Instruments & Supplies
$22.35
$0.64(2.95%)
U.S. Market opens in 15h 40m

Stevanato Group S.p.A. (STVN)

Meyka AI Score

Z

Key Financials

Market Cap6.1B
P/E Ratio38.51
EPS (TTM)$0.66
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$24.35
3 Months$16.66
1 Year Target$17.40

STVN Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Stevanato Group S.p.A. (NYSE: STVN) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Stevanato Group S.p.A.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of STVN on the NYSE shows an RSI of 69.88, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $17.40 for the NYSE listing.

Key metrics behind Stevanato Group S.p.A.'s NYSE-traded stock include a P/E ratio of 38.51 and a market capitalization of 6.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of STVN on the NYSE.

Price Performance (NYSE: STVN)

1-Day Change
3.04%
5-Day Change
4.24%
1-Month Change
16.81%
3-Month Change
26.03%
6-Month Change
39.38%
Year-to-Date (YTD) Change
11.18%
1-Year Change
-2.31%
3-Year Change
-28.58%
5-Year Change
-9.40%
All-Time (Max) Change
13.73%

Contact Information

39 04 99 31 811
Via Molinella, 17, Piombino Dese, PD, 35017

Company Facts

60,100 Employees
IPO DateJul 16, 2021
CountryIT
Actively Trading

Frequently Asked Questions